表紙:ライム病診断装置:世界市場規模予測(2020年~2028年)
市場調査レポート
商品コード
1021416

ライム病診断装置:世界市場規模予測(2020年~2028年)

Lyme Disease Diagnostic Devices - Global Market Outlook (2020-2028)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 150+ Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
ライム病診断装置:世界市場規模予測(2020年~2028年)
出版日: 2021年07月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 150+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のライム病診断装置の市場規模は、2020年に8億4,029万米ドルとなり、予測期間中に8.5%のCAGRで成長し、2028年までに16億1,386万米ドルに達すると予測されています。

ライム病の発症率の上昇、医療サービスの向上に対する政策的関心の高まり、ライム病の新しい診断テストの登場などが、市場の成長を促しています。しかし、病気に関する知識の不足や、ライム病研究の非効率性が市場の成長を妨げています。

当レポートではライム病診断装置の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、Covid-19の影響、診断テスト・診断技術タイプ・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • テクノロジー分析
  • エンドユーザー分析
  • 新興市場
  • Covid-19の影響

第4章 ポーターズのファイブフォース分析

第5章 診断テスト別

  • 血清学的テスト
    • 酵素免疫測定法(ELFA)
    • 酵素免疫測定法(ELISA)
    • ウエスタンブロット法
  • 暗視野顕微鏡
  • 免疫蛍光染色
  • リンパ球形質転換テスト
  • 核酸増幅
  • ポリメラーゼ連鎖反応(PCR)分析
  • 尿中抗原テスト

第6章 診断技術タイプ別

  • 脳磁気共鳴画像法(MRI)
  • 心エコー図
  • 心電図
  • フローサイトメトリー
  • ゲル微小液滴
  • 分子診断
  • モノクローナル抗体
  • 脊椎穿刺

第7章 エンドユーザー別

  • 臨床調査
  • 病院
  • 病理学研究室
  • 製薬産業
  • 医師のオフィス
  • 公立/私立研究所

第8章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東およびアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、ジョイントベンチャー
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の重要な戦略

第10章 企業プロファイル

  • Abbott Laboratories
  • Affymetrix Inc.
  • Alere Inc(ALR)
  • Baxter International Inc.
  • Bio-Rad Laboratories
  • Boulder Diagnostics
  • Canon U.S. Life Sciences
  • Covance Inc.
  • Fresenius Medical Care AG and Co.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • Graphene Frontiers
  • Immunetics Inc.
  • Roche Diagnostics International Ltd.
  • Siemens AG
  • T2 Biosystems
図表

List of Tables

  • Table 1 Global Lyme Disease Diagnostic Devices Market Outlook, By Region (2019-2028) (US $MN)
  • Table 2 Global Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)
  • Table 3 Global Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)
  • Table 4 Global Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)
  • Table 5 Global Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)
  • Table 6 Global Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)
  • Table 7 Global Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)
  • Table 8 Global Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)
  • Table 9 Global Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)
  • Table 10 Global Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification (2019-2028) (US $MN)
  • Table 11 Global Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)
  • Table 12 Global Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)
  • Table 13 Global Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)
  • Table 14 Global Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI) (2019-2028) (US $MN)
  • Table 15 Global Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram (2019-2028) (US $MN)
  • Table 16 Global Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram (2019-2028) (US $MN)
  • Table 17 Global Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry (2019-2028) (US $MN)
  • Table 18 Global Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)
  • Table 19 Global Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics (2019-2028) (US $MN)
  • Table 20 Global Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies (2019-2028) (US $MN)
  • Table 21 Global Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap (2019-2028) (US $MN)
  • Table 22 Global Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)
  • Table 23 Global Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)
  • Table 24 Global Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)
  • Table 25 Global Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs (2019-2028) (US $MN)
  • Table 26 Global Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries (2019-2028) (US $MN)
  • Table 27 Global Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)
  • Table 28 Global Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)
  • Table 29 North America Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)
  • Table 30 North America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)
  • Table 31 North America Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)
  • Table 32 North America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)
  • Table 33 North America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)
  • Table 34 North America Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)
  • Table 35 North America Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)
  • Table 36 North America Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)
  • Table 37 North America Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)
  • Table 38 North America Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification (2019-2028) (US $MN)
  • Table 39 North America Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)
  • Table 40 North America Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)
  • Table 41 North America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)
  • Table 42 North America Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI) (2019-2028) (US $MN)
  • Table 43 North America Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram (2019-2028) (US $MN)
  • Table 44 North America Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram (2019-2028) (US $MN)
  • Table 45 North America Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry (2019-2028) (US $MN)
  • Table 46 North America Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)
  • Table 47 North America Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics (2019-2028) (US $MN)
  • Table 48 North America Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies (2019-2028) (US $MN)
  • Table 49 North America Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap (2019-2028) (US $MN)
  • Table 50 North America Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)
  • Table 51 North America Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)
  • Table 52 North America Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)
  • Table 53 North America Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs (2019-2028) (US $MN)
  • Table 54 North America Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries (2019-2028) (US $MN)
  • Table 55 North America Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)
  • Table 56 North America Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)
  • Table 57 Europe Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)
  • Table 58 Europe Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)
  • Table 59 Europe Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)
  • Table 60 Europe Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)
  • Table 61 Europe Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)
  • Table 62 Europe Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)
  • Table 63 Europe Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)
  • Table 64 Europe Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)
  • Table 65 Europe Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)
  • Table 66 Europe Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification (2019-2028) (US $MN)
  • Table 67 Europe Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)
  • Table 68 Europe Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)
  • Table 69 Europe Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)
  • Table 70 Europe Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI) (2019-2028) (US $MN)
  • Table 71 Europe Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram (2019-2028) (US $MN)
  • Table 72 Europe Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram (2019-2028) (US $MN)
  • Table 73 Europe Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry (2019-2028) (US $MN)
  • Table 74 Europe Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)
  • Table 75 Europe Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics (2019-2028) (US $MN)
  • Table 76 Europe Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies (2019-2028) (US $MN)
  • Table 77 Europe Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap (2019-2028) (US $MN)
  • Table 78 Europe Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)
  • Table 79 Europe Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)
  • Table 80 Europe Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)
  • Table 81 Europe Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs (2019-2028) (US $MN)
  • Table 82 Europe Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries (2019-2028) (US $MN)
  • Table 83 Europe Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)
  • Table 84 Europe Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)
  • Table 85 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)
  • Table 86 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)
  • Table 87 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)
  • Table 88 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)
  • Table 89 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)
  • Table 90 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)
  • Table 91 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)
  • Table 92 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)
  • Table 93 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)
  • Table 94 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification (2019-2028) (US $MN)
  • Table 95 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)
  • Table 96 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)
  • Table 97 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)
  • Table 98 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI) (2019-2028) (US $MN)
  • Table 99 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram (2019-2028) (US $MN)
  • Table 100 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram (2019-2028) (US $MN)
  • Table 101 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry (2019-2028) (US $MN)
  • Table 102 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)
  • Table 103 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics (2019-2028) (US $MN)
  • Table 104 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies (2019-2028) (US $MN)
  • Table 105 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap (2019-2028) (US $MN)
  • Table 106 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)
  • Table 107 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)
  • Table 108 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)
  • Table 109 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs (2019-2028) (US $MN)
  • Table 110 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries (2019-2028) (US $MN)
  • Table 111 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)
  • Table 112 Asia Pacific Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)
  • Table 113 South America Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)
  • Table 114 South America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)
  • Table 115 South America Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)
  • Table 116 South America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)
  • Table 117 South America Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)
  • Table 118 South America Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)
  • Table 119 South America Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)
  • Table 120 South America Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)
  • Table 121 South America Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)
  • Table 122 South America Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification (2019-2028) (US $MN)
  • Table 123 South America Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)
  • Table 124 South America Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)
  • Table 125 South America Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)
  • Table 126 South America Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI) (2019-2028) (US $MN)
  • Table 127 South America Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram (2019-2028) (US $MN)
  • Table 128 South America Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram (2019-2028) (US $MN)
  • Table 129 South America Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry (2019-2028) (US $MN)
  • Table 130 South America Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)
  • Table 131 South America Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics (2019-2028) (US $MN)
  • Table 132 South America Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies (2019-2028) (US $MN)
  • Table 133 South America Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap (2019-2028) (US $MN)
  • Table 134 South America Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)
  • Table 135 South America Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)
  • Table 136 South America Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)
  • Table 137 South America Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs (2019-2028) (US $MN)
  • Table 138 South America Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries (2019-2028) (US $MN)
  • Table 139 South America Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)
  • Table 140 South America Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)
  • Table 141 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Country (2019-2028) (US $MN)
  • Table 142 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Test (2019-2028) (US $MN)
  • Table 143 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Serological Test (2019-2028) (US $MN)
  • Table 144 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Fluorescent Immunoassay (ELFA) (2019-2028) (US $MN)
  • Table 145 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2019-2028) (US $MN)
  • Table 146 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Western Blot (2019-2028) (US $MN)
  • Table 147 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Dark Field Microscopy (2019-2028) (US $MN)
  • Table 148 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Immunofluorescent Staining (2019-2028) (US $MN)
  • Table 149 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Lymphocytic Transformation Test (2019-2028) (US $MN)
  • Table 150 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Nucleic Acid Amplification (2019-2028) (US $MN)
  • Table 151 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Polymerase Chain Reaction (PCR) Analysis (2019-2028) (US $MN)
  • Table 152 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Urine Antigen Tests (2019-2028) (US $MN)
  • Table 153 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Diagnostic Technologies Type (2019-2028) (US $MN)
  • Table 154 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Brain Magnetic Resonance Imaging (MRI) (2019-2028) (US $MN)
  • Table 155 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Echocardiogram (2019-2028) (US $MN)
  • Table 156 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Electrocardiogram (2019-2028) (US $MN)
  • Table 157 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Flow Cytometry (2019-2028) (US $MN)
  • Table 158 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Gel Microdroplets (2019-2028) (US $MN)
  • Table 159 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Molecular Diagnostics (2019-2028) (US $MN)
  • Table 160 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Monoclonal Antibodies (2019-2028) (US $MN)
  • Table 161 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Spinal Tap (2019-2028) (US $MN)
  • Table 162 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By End User (2019-2028) (US $MN)
  • Table 163 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Clinical Research Institute (2019-2028) (US $MN)
  • Table 164 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Hospitals (2019-2028) (US $MN)
  • Table 165 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Pathology Labs (2019-2028) (US $MN)
  • Table 166 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Pharmaceutical Industries (2019-2028) (US $MN)
  • Table 167 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Physician's Office (2019-2028) (US $MN)
  • Table 168 Middle East & Africa Lyme Disease Diagnostic Devices Market Outlook, By Public/Private Laboratories (2019-2028) (US $MN)
目次
Product Code: SMRC20699

According to Stratistics MRC, the Global Lyme Disease Diagnostic Devices Market is accounted for $840.29 million in 2020 and is expected to reach $1,613.86 million by 2028 growing at a CAGR of 8.5% during the forecast period. Upsurge in incidence of Lyme disease, growing policy attention on improving health care services, and the advent of new diagnostic tests for Lyme disease are driving the market growth. However, lack of knowledge of the disease and ineffectiveness in Lyme disease research are hampering the growth of the market.

Lyme disease is a vector-borne illness which is spread by infected ticks. It is not easy to diagnose for many reasons, such as inflammation, dizziness, fatigue, joint or body pains, headaches that are quite common with other diseases, including circular red rash termed as erythema migrants (EM), which doesn't appear commonly. Hence, it is important to have the advanced diagnostic tool to discover potential targets of Lyme disease instantaneously. There is a substantial need to design rapid, point-of-care tests to determine whether patients are infected with 'Borrelia burgdorferi', the bacterium that causes Lyme disease, as early active assessment is imperative to detect to make prompt treatment.

Based on the end user, the hospitals segment is going to have lucrative growth during the forecast period. Hospitals are well-equipped to handle patient flow and employ latest diagnostic and treatment techniques. These factors are primarily responsible for the greater market share of hospitals. By geography, North America is going to have high growth during the forecast period owing to high incidence of Lyme disease and existence of state-of-the-art healthcare infrastructure.

Some of the key players profiled in the Lyme Disease Diagnostic Devices Market include Abbott Laboratories, Affymetrix Inc., Alere Inc (ALR), Baxter International Inc., Bio-Rad Laboratories, Boulder Diagnostics, Canon U.S. Life Sciences, Covance Inc., Fresenius Medical Care AG and Co., GlaxoSmithKline Pharmaceuticals Ltd., Graphene Frontiers, Immunetics Inc., Roche Diagnostics International Ltd., Siemens AG and T2 Biosystems.

Diagnostic Tests Covered:

  • Serological Test
  • Dark Field Microscopy
  • Immunofluorescent Staining
  • Lymphocytic Transformation Test
  • Nucleic Acid Amplification
  • Polymerase Chain Reaction (PCR) Analysis
  • Urine Antigen Tests

Diagnostic Technologies Types Covered:

  • Brain Magnetic Resonance Imaging (MRI)
  • Echocardiogram
  • Electrocardiogram
  • Flow Cytometry
  • Gel Microdroplets
  • Molecular Diagnostics
  • Monoclonal Antibodies
  • Spinal Tap

End Users Covered:

  • Clinical Research Institute
  • Hospitals
  • Pathology Labs
  • Pharmaceutical Industries
  • Physician's Office
  • Public/Private Laboratories

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lyme Disease Diagnostic Devices Market, By Diagnostic Test

  • 5.1 Introduction
  • 5.2 Serological Test
    • 5.2.1 Enzyme-Linked Fluorescent Immunoassay (ELFA)
    • 5.2.2 Enzyme-Linked Immunosorbent Assay (ELISA)
    • 5.2.3 Western Blot
  • 5.3 Dark Field Microscopy
  • 5.4 Immunofluorescent Staining
  • 5.5 Lymphocytic Transformation Test
  • 5.6 Nucleic Acid Amplification
  • 5.7 Polymerase Chain Reaction (PCR) Analysis
  • 5.8 Urine Antigen Tests

6 Global Lyme Disease Diagnostic Devices Market, By Diagnostic Technologies Type

  • 6.1 Introduction
  • 6.2 Brain Magnetic Resonance Imaging (MRI)
  • 6.3 Echocardiogram
  • 6.4 Electrocardiogram
  • 6.5 Flow Cytometry
  • 6.6 Gel Microdroplets
  • 6.7 Molecular Diagnostics
  • 6.8 Monoclonal Antibodies
  • 6.9 Spinal Tap

7 Global Lyme Disease Diagnostic Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Clinical Research Institute
  • 7.3 Hospitals
  • 7.4 Pathology Labs
  • 7.5 Pharmaceutical Industries
  • 7.6 Physician's Office
  • 7.7 Public/Private Laboratories

8 Global Lyme Disease Diagnostic Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Affymetrix Inc.
  • 10.3 Alere Inc (ALR)
  • 10.4 Baxter International Inc.
  • 10.5 Bio-Rad Laboratories
  • 10.6 Boulder Diagnostics
  • 10.7 Canon U.S. Life Sciences
  • 10.8 Covance Inc.
  • 10.9 Fresenius Medical Care AG and Co.
  • 10.10 GlaxoSmithKline Pharmaceuticals Ltd.
  • 10.11 Graphene Frontiers
  • 10.12 Immunetics Inc.
  • 10.13 Roche Diagnostics International Ltd.
  • 10.14 Siemens AG
  • 10.15 T2 Biosystems